Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11918294rdf:typepubmed:Citationlld:pubmed
pubmed-article:11918294lifeskim:mentionsumls-concept:C0029431lld:lifeskim
pubmed-article:11918294lifeskim:mentionsumls-concept:C0018956lld:lifeskim
pubmed-article:11918294lifeskim:mentionsumls-concept:C1456820lld:lifeskim
pubmed-article:11918294lifeskim:mentionsumls-concept:C1523116lld:lifeskim
pubmed-article:11918294lifeskim:mentionsumls-concept:C0005533lld:lifeskim
pubmed-article:11918294lifeskim:mentionsumls-concept:C0086597lld:lifeskim
pubmed-article:11918294pubmed:issue2lld:pubmed
pubmed-article:11918294pubmed:dateCreated2002-3-28lld:pubmed
pubmed-article:11918294pubmed:abstractTextTumor necrosis factor-alpha (TNF) is a potent osteoclastogenic cytokine that has a fundamental role in the pathogenesis of implant particle-induced osteolysis. The nuclear transcription factor NF-kappaB mediates TNF signaling and this transcription complex is necessary for osteoclastogenesis. Because polymethylmethacrylate (PMMA) particles cause osteolysis, we reasoned the PMMA would induce NF-kappaB activation. In fact, we find that exposure of osteoclast precursors, in the form of colony stimulating factor-1 (CSF-1) dependent murine bone marrow macrophages, to PMMA particles prompts nuclear translocation and activation of NF-kappaB. Supershift assays confirm the presence of the p50 and p65 NF-kappaB subunits in the activated transcription factor. Particle-induced NF-kappaB activation is equal in both wild type and LPS- hyporesponsive cells indicating that the phenomenon does not represent endotoxin contamination. A soluble, competitive inhibitor of TNF (huTNFr:Fc) dampens particle-directed NF-kappaB activation and this response is also abrogated in TNF-/- osteoclast precursors. Thus, PMMA particle activation of NF-kappaB is a secondary event resulting from enhanced TNF expression and is independent of LPS contamination.lld:pubmed
pubmed-article:11918294pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918294pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918294pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918294pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918294pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918294pubmed:languageenglld:pubmed
pubmed-article:11918294pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918294pubmed:citationSubsetIMlld:pubmed
pubmed-article:11918294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918294pubmed:statusMEDLINElld:pubmed
pubmed-article:11918294pubmed:monthMarlld:pubmed
pubmed-article:11918294pubmed:issn0736-0266lld:pubmed
pubmed-article:11918294pubmed:authorpubmed-author:ChenShaopingSlld:pubmed
pubmed-article:11918294pubmed:authorpubmed-author:ClohisyJohn...lld:pubmed
pubmed-article:11918294pubmed:authorpubmed-author:TeitelbaumSte...lld:pubmed
pubmed-article:11918294pubmed:authorpubmed-author:ErdmannJeanne...lld:pubmed
pubmed-article:11918294pubmed:authorpubmed-author:Abu-AmerYouse...lld:pubmed
pubmed-article:11918294pubmed:issnTypePrintlld:pubmed
pubmed-article:11918294pubmed:volume20lld:pubmed
pubmed-article:11918294pubmed:ownerNLMlld:pubmed
pubmed-article:11918294pubmed:authorsCompleteYlld:pubmed
pubmed-article:11918294pubmed:pagination174-81lld:pubmed
pubmed-article:11918294pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:11918294pubmed:meshHeadingpubmed-meshheading:11918294...lld:pubmed
pubmed-article:11918294pubmed:meshHeadingpubmed-meshheading:11918294...lld:pubmed
pubmed-article:11918294pubmed:meshHeadingpubmed-meshheading:11918294...lld:pubmed
pubmed-article:11918294pubmed:meshHeadingpubmed-meshheading:11918294...lld:pubmed
pubmed-article:11918294pubmed:meshHeadingpubmed-meshheading:11918294...lld:pubmed
pubmed-article:11918294pubmed:meshHeadingpubmed-meshheading:11918294...lld:pubmed
pubmed-article:11918294pubmed:meshHeadingpubmed-meshheading:11918294...lld:pubmed
pubmed-article:11918294pubmed:meshHeadingpubmed-meshheading:11918294...lld:pubmed
pubmed-article:11918294pubmed:meshHeadingpubmed-meshheading:11918294...lld:pubmed
pubmed-article:11918294pubmed:meshHeadingpubmed-meshheading:11918294...lld:pubmed
pubmed-article:11918294pubmed:meshHeadingpubmed-meshheading:11918294...lld:pubmed
pubmed-article:11918294pubmed:meshHeadingpubmed-meshheading:11918294...lld:pubmed
pubmed-article:11918294pubmed:meshHeadingpubmed-meshheading:11918294...lld:pubmed
pubmed-article:11918294pubmed:meshHeadingpubmed-meshheading:11918294...lld:pubmed
pubmed-article:11918294pubmed:meshHeadingpubmed-meshheading:11918294...lld:pubmed
pubmed-article:11918294pubmed:meshHeadingpubmed-meshheading:11918294...lld:pubmed
pubmed-article:11918294pubmed:year2002lld:pubmed
pubmed-article:11918294pubmed:articleTitleTumor necrosis factor-alpha mediates polymethylmethacrylate particle-induced NF-kappaB activation in osteoclast precursor cells.lld:pubmed
pubmed-article:11918294pubmed:affiliationDepartment of Orthopaedic Surgery, Barnes-Jewish Hospital at Washington University School of Medicine, St. Louis, MO 63110, USA. jclohisy@msnotes.wustl.edulld:pubmed
pubmed-article:11918294pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11918294pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:11918294pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11918294lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11918294lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11918294lld:pubmed